Author:
Zhang Shuangshuang,Zhao Ludan,Peng Xu,Sun Qiaomei,Liao Xiaoxiang,Gan Na,Zhao Gang,Li Hui
Funder
Sichuan Province Science and Technology Support Program
Subject
Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology
Reference39 articles.
1. Lenvatinib slows progression of thyroid cancer;Johnson;Cancer Discov.,2014
2. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer;Schlumberger;New Engl. J. Med.,2015
3. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial;Motzer;Lancet Oncol.,2015
4. Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan;Kobayashi;J. Gastroenterol.,2019
5. Lenvatinib mesylate to treat hepatocellular carcinoma;Ielasi;Drug Today,2019
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献